BioLife Solutions Sees Prelim Q4 Revenue $32.7M Vs $33.82M Est.
Portfolio Pulse from Benzinga Newsdesk
BioLife Solutions announced preliminary Q4 revenue of $32.7M, which is below the estimated $33.82M.
January 08, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioLife Solutions reported preliminary Q4 revenue of $32.7M, missing the estimate of $33.82M.
The reported preliminary revenue for Q4 by BioLife Solutions is lower than the market expectations, which can lead to negative investor sentiment and a potential decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100